Manufacturer
Novo Nordisk
Contents
Repaglinide
Indication
Type 2 diabetes [non-insulin-dependent diabetes mellitus (NIDDM)] whose hyperglycaemia is not controlled satisfactorily by diet, weight reduction and exercise. NovoNorm can be used in combination with metformin. Combination therapy with NovoNorm and metformin results in synergistic improvement in glycaemic control compared to NovoNorm or metformin alone
Instruction
Drug interaction
Malaysia
